Genome-first approach to rare EYA4 variants and cardio-auditory phenotypes in adults

• DOI: 10.1007/s00439-021-02263-6
• Publication Date: 2021-03-21T10:02:28Z
• Authors: Shadi Ahmadmehrabi; Binglan Li; Joseph Park; Batsal Devkota; Marijana Vujkovic; Yi-An Ko; David Van Wagoner; W.H. Wilson Tang; Ian Krantz; Marylyn Ritchie; Jason Brant; Michael J. Rucken...; Douglas J. Epstein; Daniel J. Rader
• Keywords: Male; 0301 basic medicine; Genome, Human; Black People; Gene Expression; Pennsylvania; Severity of Illness Index; White People; 3. Good health; Electrocardiography; 03 medical and health sciences; Phenotype; Audiometry; Echocardiography; Mutation; Exome Sequencing; Trans-Activators; Humans; Cardiomyopathies; Hearing Loss; Biological Specimen Banks

While newborns and children with hearing loss are routinely offered genetic testing, adults are rarely clinically tested for a genetic etiology. One clinically actionable result from genetic testing in children is the discovery of variants in syndromic hearing loss genes. EYA4 is a known hearing loss gene which is also involved in important pathways in cardiac tissue. The pleiotropic effects of rare EYA4 variants are poorly understood and their prevalence in a large cohort has not been previously reported. We investigated cardio-auditory phenotypes in 11,451 individuals in a large biobank using a rare variant, genome-first approach to EYA4. We filtered 256 EYA4 variants carried by 6737 participants to 26 rare and predicted deleterious variants carried by 42 heterozygotes. We aggregated predicted deleterious EYA4 gene variants into a combined variable (i.e. "gene burden") and performed association studies across phenotypes compared to wildtype controls. We validated findings with replication in three independent cohorts and human tissue expression data. EYA4 gene burden was significantly associated with audiometric-proven HL (p = [Formula: see text], Mobitz Type II AV block (p = [Formula: see text]) and the syndromic presentation of HL and primary cardiomyopathy (p = 0.0194). Analyses on audiogram, echocardiogram, and electrocardiogram data validated these associations. Prior reports have focused on identifying variants in families with severe or syndromic phenotypes. In contrast, we found, using a genotype-first approach, that gene burden in EYA4 is associated with more subtle cardio-auditory phenotypes in an adult medical biobank population, including cardiac conduction disorders which have not been previously reported. We show the value of using a focused approach to uncover human disease related to pleiotropic gene variants and suggest a role for genetic testing in adults presenting with hearing loss.